Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 1 min

Patent Foramen Ovale in Patients with Neurologic Events: When, How, and Whom to Treat

AI Summary
  • Use causal attribution to select patients; apply ROPE score and PFO-Associated Stroke Causal Likelihood to identify those who benefit from closure.
  • Delay closure until atrial fibrillation is excluded; define indication thresholds and circumstances to withhold closure based on risk assessment.
  • Procedure choices, device selection, antithrombotic strategy, and AF management are key; heart-brain team judgement for patients over 60 and monitoring uncertainty.
Summarise with AI (MRCPsych/FRANZCP)

Heart Fail Clin. 2026 Oct;22(4):439-449. doi: 10.1016/j.hfc.2026.07.004. Epub 2026 Aug 4.

ABSTRACT

Patent foramen ovale (PFO) is the commonest interatrial communication and a frequent, though often incidental, finding after cryptogenic stroke. Selecting whom to treat rests on causal attribution: the Risk of Paradoxic Embolism score and PFO-Associated Stroke Causal Likelihood classification identify the patients in whom closure works. Deciding when to treat sets the indication threshold, defines when to withhold closure, and requires excluding atrial fibrillation (AF) first. Treating well covers the procedure, device and antithrombotic strategy, and management of the AF trade-off. Uncertainty persists in patients aged more than 60 and in preclosure rhythm monitoring, where heart-brain team judgment matters most.

PMID:42716654 | DOI:10.1016/j.hfc.2026.07.004

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

Save as PDF

My Revision List

close chatgpt icon
ChatGPT

Enter your request.

← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD